top of page
OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation
TechCrunch AI
Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.
讞讘专转 讛讘讬讜讟拽 Chai Discovery, 讛谞转诪讻转 注诇 讬讚讬 OpenAI, 讙讬讬住讛 住讻讜诐 诪专砖讬诐 砖诇 130 诪讬诇讬讜谉 讚讜诇专 讘住讘讘 B, 诪讛 砖诪爪讬讘 讗转 砖讜讜讬讛 注诇 1.3 诪讬诇讬讗专讚 讚讜诇专 讜讛讜驻讱 讗讜转讛 诇讬讜谞讬拽讜专谉. 讛讞讘专讛 诪驻转讞转 诪讜讚诇讬 讬住讜讚 讛诪讘讜住住讬诐 注诇 讘讬谞讛 诪诇讗讻讜转讬转, 砖诪讟专转诐 诇讞讝讜转 讗讬谞讟专讗拽爪讬讜转 讘讬谉 诪讜诇拽讜诇讜转 注诇 诪谞转 诇转讻谞转 讗讜转谉 诪讞讚砖 诇驻讬转讜讞 转专讜驻讜转 讞讚砖谞讬讜转.
bottom of page